Askeladden Advocates against Tribal Sovereign Immunity for Inter Partes Review Proceedings
Submitted amicus brief in support of PTAB's decision finding tribal sovereign immunity inapplicable in six IPRs involving Restasis® patents.
PTAB Finds N5 Technologies Patent to be Unpatentable Following Challenge from Askeladden
Askeladden successfully proves that all eleven claims of the mobile authentication patent were unpatentable.
Askeladden Petitions for Review of Digital Verification Systems Patent
Argues that prior art renders all claims anticipated or obvious.
Our Mission
To improve patent quality, supporting good IP practices, and addressing questionable patent holder behaviors.
Why Patent Quality Matters
Low-quality patents stifle innovation and exposes companies to frivolous, expensive lawsuits.
Learn more about our efforts to improve the understanding, use and reliability of patents in financial services and elsewhere.
Answers to the most common questions about the Patent Quality Initiative.
Your resource on patent litigation and IPR filings.
Askeladden Advocates for Ability of Non-Defendant IPR Petitioners to Appeal Adverse PTAB Decisions
September 20, 2018
Askeladden filed an amicus brief this week advocating for en banc review to correct the Federal Circuit’s standing jurisprudence with respect to appeals of Inter Partes Review decisions.
Rethinking Article III Standing in IPR Appeals at the Federal Circuit
June 11, 2018
When Congress grants a petitioner in an IPR proceeding the right to petition the government to seek specific relief, and when the government (arguably improperly) denies such relief, the denial of such relief is a sufficient injury in fact to provide the Courts with constitutional authority under Article III to hear appeal from that denial by the unsuccessful petitioner.
May 21, 2018
Submitted amicus brief in support of PTAB’s decision finding tribal sovereign immunity inapplicable in six IPRs involving Restasis® patents
April 25, 2018
March 7, 2018
PTAB Denies St. Regis Mohawk Tribe’s Request for Sovereign Immunity in Challenges of Restasis Patents
Askeladden filed an amicus brief arguing against applicability of tribal sovereign immunity in IPR proceedings.
